−0.15HKD
−159.91 MHKD
62.54 MHKD
182.20 M
About ASCLETIS PHARMA INC
Sector
Industry
CEO
Jinzi J. Wu
Website
Headquarters
Hangzhou
Employees (FY)
219
Founded
2013
ISIN
KYG0520K1094
FIGI
BBG00LG50P53
Ascletis Pharma, Inc. engages in the research and development, production, marketing, and sale of pharmaceutical products. The company was founded by Jinzi Jason Wu and is headquartered in Hangzhou, China.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 1672 is 1.27 HKD — it has decreased by 2.31% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange ASCLETIS PHARMA INC stocks are traded under the ticker 1672.
ASCLETIS PHARMA INC is going to release the next earnings report on Aug 19, 2024. Keep track of upcoming events with our Earnings Calendar.
1672 stock is 3.17% volatile and has beta coefficient of 0.41. Check out the list of the most volatile stocks — is ASCLETIS PHARMA INC there?
One year price forecast for ASCLETIS PHARMA INC has a max estimate of 3.80 HKD and a min estimate of 2.16 HKD.
1672 earnings for the last quarter are −0.02 HKD whereas the estimation was −0.02 HKD which accounts for 25.24% surprise. Estimated earnings for the next quarter are −0.08 HKD. See more details about ASCLETIS PHARMA INC earnings.
ASCLETIS PHARMA INC revenue for the last quarter amounts to 49.85 M HKD despite the estimated figure of 50.66 M HKD. In the next quarter revenue is expected to reach 22.53 M HKD.
Yes, you can track ASCLETIS PHARMA INC financials in yearly and quarterly reports right on TradingView.
1672 stock has fallen by 5.22% compared to the previous week, the month change is a 21.60% fall, over the last year ASCLETIS PHARMA INC has showed a 52.08% decrease.
1672 net income for the last quarter is −138.45 M HKD, while the quarter before that showed −18.73 M HKD of net income which accounts for −639.30% change. Track more ASCLETIS PHARMA INC financial stats to get the full picture.
Today ASCLETIS PHARMA INC has the market capitalization of 1.31 B, it has decreased by 2.19% over the last week.
No, 1672 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 1672 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASCLETIS PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 219.00 employees. See our rating of the largest employees — is ASCLETIS PHARMA INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASCLETIS PHARMA INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASCLETIS PHARMA INC stock shows the strong sell signal. See more of ASCLETIS PHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ASCLETIS PHARMA INC future price: according to them, 1672 price has a max estimate of 3.80 HKD and a min estimate of 2.16 HKD. Read a more detailed ASCLETIS PHARMA INC forecast: see what analysts think of ASCLETIS PHARMA INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASCLETIS PHARMA INC EBITDA is −315.11 M HKD, and current EBITDA margin is −509.45%. See more stats in ASCLETIS PHARMA INC financial statements.